Global and United States High Content Imaging Market Report & Forecast 2022-2028

High content imaging applies automated microscopy, fluorescent detection and multi-parameter algorithms to visualize and quantify the interaction of therapeutics in cell populations.
Market Analysis and Insights: Global and United States High Content Imaging Market
This report focuses on global and United States High Content Imaging market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global High Content Imaging market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Instruments accounting for % of the High Content Imaging global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Primary and Secondary Screening was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
High content imaging is a method used in biological research and drug discovery to identify substances that change the phenotype of cells in a desired manner, such as small molecules, peptides, or RNAi.
Global High Content Imaging Scope and Market Size
High Content Imaging market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global High Content Imaging market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the High Content Imaging market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Instruments
Consumables
Software
Services
Accessories
Segment by Application
Primary and Secondary Screening
Target Identification and Validation
Toxicity Studies
Compound Profiling
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Albany Molecular Research
Cell Signaling Technology
Danaher Corp.
GE Healthcare
Instrument Systems
Perkinelmer Inc.
Thermo Fisher Scientific Inc.
Becton Dickinson
Biotek Instruments Inc.
Bio-Rad Laboratories Inc.
Yokogawa Electric Corporation
Merck Millipore